世界の免疫学的治療薬市場規模・現状・予測2021-2027

【英語タイトル】Global Immunotherapeutic Drugs Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21JNE3800)・商品コード:QY21JNE3800
・発行会社(調査会社):QYResearch
・発行日:2021年6月
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥510,900見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥766,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、免疫学的治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・免疫学的治療薬の市場動向
・企業の競争状況、市場シェア
・免疫学的治療薬の種類別市場規模(モノクローナル抗体、ワクチン、チェックポイント阻害剤、インターフェロン)
・免疫学的治療薬の用途別市場規模(病院、診療所、その他)
・免疫学的治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・免疫学的治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・免疫学的治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・免疫学的治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・免疫学的治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Merck、Novartis、Johnson & Johnson、GlaxoSmithKline、AbbVie、ELI Lilly、Amgen、AstraZeneca、Bristol-Mysers Squibb)
・結論
【レポートの概要】

Immunotherapy is a cancer treatment that enhances the body’s natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.

Market Analysis and Insights: Global Immunotherapeutic Drugs Market
The global Immunotherapeutic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunotherapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunotherapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunotherapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunotherapeutic Drugs market.

Global Immunotherapeutic Drugs Scope and Market Size
Immunotherapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibody
1.2.3 Vaccines
1.2.4 Checkpoint Inhibitor
1.2.5 Interferon
1.3 Market by Application
1.3.1 Global Immunotherapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunotherapeutic Drugs Market Perspective (2016-2027)
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunotherapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Immunotherapeutic Drugs Industry Dynamic
2.3.1 Immunotherapeutic Drugs Market Trends
2.3.2 Immunotherapeutic Drugs Market Drivers
2.3.3 Immunotherapeutic Drugs Market Challenges
2.3.4 Immunotherapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immunotherapeutic Drugs Players by Revenue
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2020
3.5 Immunotherapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Immunotherapeutic Drugs Product Solution and Service
3.7 Date of Enter into Immunotherapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunotherapeutic Drugs Breakdown Data by Type
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Immunotherapeutic Drugs Breakdown Data by Application
5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2016-2027)
6.2 North America Immunotherapeutic Drugs Market Size by Type
6.2.1 North America Immunotherapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America Immunotherapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America Immunotherapeutic Drugs Market Size by Type (2016-2027)
6.3 North America Immunotherapeutic Drugs Market Size by Application
6.3.1 North America Immunotherapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America Immunotherapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America Immunotherapeutic Drugs Market Size by Application (2016-2027)
6.4 North America Immunotherapeutic Drugs Market Size by Country
6.4.1 North America Immunotherapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America Immunotherapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2016-2027)
7.2 Europe Immunotherapeutic Drugs Market Size by Type
7.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Immunotherapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe Immunotherapeutic Drugs Market Size by Application
7.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Immunotherapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe Immunotherapeutic Drugs Market Size by Country
7.4.1 Europe Immunotherapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immunotherapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunotherapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immunotherapeutic Drugs Market Size (2016-2027)
9.2 Latin America Immunotherapeutic Drugs Market Size by Type
9.2.1 Latin America Immunotherapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Immunotherapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Immunotherapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America Immunotherapeutic Drugs Market Size by Application
9.3.1 Latin America Immunotherapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Immunotherapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Immunotherapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America Immunotherapeutic Drugs Market Size by Country
9.4.1 Latin America Immunotherapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Immunotherapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immunotherapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunotherapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapeutic Drugs Introduction
11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapeutic Drugs Introduction
11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapeutic Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Immunotherapeutic Drugs Introduction
11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 ELI Lilly
11.7.1 ELI Lilly Company Details
11.7.2 ELI Lilly Business Overview
11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.7.5 ELI Lilly Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Immunotherapeutic Drugs Introduction
11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Details
11.10.2 Bristol-Mysers Squibb Business Overview
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2016-2021)
11.10.5 Bristol-Mysers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Vaccines
Table 4. Key Players of Checkpoint Inhibitor
Table 5. Key Players of Interferon
Table 6. Global Immunotherapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immunotherapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immunotherapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immunotherapeutic Drugs Market Share by Regions (2016-2021)
Table 10. Global Immunotherapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immunotherapeutic Drugs Market Share by Regions (2022-2027)
Table 12. Immunotherapeutic Drugs Market Trends
Table 13. Immunotherapeutic Drugs Market Drivers
Table 14. Immunotherapeutic Drugs Market Challenges
Table 15. Immunotherapeutic Drugs Market Restraints
Table 16. Global Immunotherapeutic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immunotherapeutic Drugs Market Share by Players (2016-2021)
Table 18. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2020)
Table 19. Ranking of Global Top Immunotherapeutic Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immunotherapeutic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immunotherapeutic Drugs Product Solution and Service
Table 23. Date of Enter into Immunotherapeutic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Immunotherapeutic Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Immunotherapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Immunotherapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Immunotherapeutic Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Immunotherapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Immunotherapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Immunotherapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Immunotherapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Immunotherapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Immunotherapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immunotherapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Immunotherapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Immunotherapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Immunotherapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Immunotherapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immunotherapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immunotherapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immunotherapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Immunotherapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Immunotherapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Immunotherapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Immunotherapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immunotherapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Immunotherapeutic Drugs Product
Table 66. Roche Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Immunotherapeutic Drugs Product
Table 71. Merck Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Immunotherapeutic Drugs Product
Table 76. Novartis Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Immunotherapeutic Drugs Product
Table 81. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Immunotherapeutic Drugs Product
Table 86. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Immunotherapeutic Drugs Product
Table 91. AbbVie Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 92. AbbVie Recent Development
Table 93. ELI Lilly Company Details
Table 94. ELI Lilly Business Overview
Table 95. ELI Lilly Immunotherapeutic Drugs Product
Table 96. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 97. ELI Lilly Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 101. Amgen Recent Development
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Immunotherapeutic Drugs Product
Table 105. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 106. AstraZeneca Recent Development
Table 107. Bristol-Mysers Squibb Company Details
Table 108. Bristol-Mysers Squibb Business Overview
Table 109. Bristol-Mysers Squibb Immunotherapeutic Drugs Product
Table 110. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2016-2021) & (US$ Million)
Table 111. Bristol-Mysers Squibb Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapeutic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibody Features
Figure 3. Vaccines Features
Figure 4. Checkpoint Inhibitor Features
Figure 5. Interferon Features
Figure 6. Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Immunotherapeutic Drugs Report Years Considered
Figure 11. Global Immunotherapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Immunotherapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Immunotherapeutic Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Immunotherapeutic Drugs Market Share by Regions (2022-2027)
Figure 15. Global Immunotherapeutic Drugs Market Share by Players in 2020
Figure 16. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2020
Figure 18. Global Immunotherapeutic Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Immunotherapeutic Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Immunotherapeutic Drugs Market Share by Type (2016-2027)
Figure 22. North America Immunotherapeutic Drugs Market Share by Application (2016-2027)
Figure 23. North America Immunotherapeutic Drugs Market Share by Country (2016-2027)
Figure 24. United States Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immunotherapeutic Drugs Market Share by Type (2016-2027)
Figure 28. Europe Immunotherapeutic Drugs Market Share by Application (2016-2027)
Figure 29. Europe Immunotherapeutic Drugs Market Share by Country (2016-2027)
Figure 30. Germany Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immunotherapeutic Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Immunotherapeutic Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Immunotherapeutic Drugs Market Share by Region (2016-2027)
Figure 40. China Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immunotherapeutic Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Immunotherapeutic Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Immunotherapeutic Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immunotherapeutic Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Immunotherapeutic Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Immunotherapeutic Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Immunotherapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 65. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 68. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


★調査レポート[世界の免疫学的治療薬市場規模・現状・予測2021-2027] (コード:QY21JNE3800)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の免疫学的治療薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆